RankAlpha logo
Back to Rankings

SVRA

SavaraC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
SVRA vs peer average
59/100
SVRA vs. peer average (C vs. D)
Grade spread
B 2 · C 2 · D 6 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ANAB is the first available peer comparator.

Small-cap biotech with similar market value; useful mainly as a single-program/event-risk comparator rather than an indication match.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerANABAnaptysBio
SVRA
Savara
ANAB
AnaptysBio
Grade
C
C
Momentum
21
32
Value
41
50
Sentiment
70
59
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed

Grade position vs ANAB

SVRA / ANAB
Grade Position
In line
SVRA vs. peer average (C vs. D)
59/100
Momentum
21
ANAB
Value
41
ANAB
Sentiment
70
SVRA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SVRA
1
ANAB
ANAB
C
60/100
Even
2
IMTX
IMTX
B
80/100
-1
3
NVAX
NVAX
D
40/100
+1
4
SANA
Sana Biotechnology Inc Common
D
40/100
+1
5
IVA
Inventiva SA ADR
D
40/100
+1
ANAB is the first peer returned for this comparison set.